Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02056041|
Recruitment Status : Completed
First Posted : February 5, 2014
Last Update Posted : June 18, 2014
|Condition or disease||Intervention/treatment|
|Hepatectomy Hepatecellular Carcinoma Cirrhosis||Procedure: Hepatectomy|
|Study Type :||Observational|
|Actual Enrollment :||336 participants|
|Official Title:||Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma: Validation on 336 Consecutive Hepatectomies.|
|Study Start Date :||January 2004|
|Actual Primary Completion Date :||December 2013|
Hepatectomy for HCC
Patients submitted to surgery for HCC
- Safety of surgery for HCC [ Time Frame: 90 days ]The primary endpoint was the validation of our selection criteria for safe hepatectomy for HCC in regards to postoperative complications. The role of total bilirubin and cholinesterases was analzyed together with other clinical parameters.
- Score systems HCC [ Time Frame: 90 days ]The secondary endpoint was the testing of the most common score systems for HCC, which are the CPT score, the MELD score, and the APRI score.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02056041
|Humanitas Research Hospital|
|Rozzano, Milan, Italy, 20089|